VIVIAN MIHAILESCU: Open Payments
NPI 1326013681 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,167 in 43 payments from 8 companies in 2025. Trend: 2023 $1,337 · 2024 $1,336 · 2025 $1,167
Food & beverage: $1,167
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 7 | $231 |
| Janssen Pharmaceuticals, Inc | 9 | $215 |
| Alkermes, Inc. | 8 | $206 |
| Lundbeck LLC | 6 | $168 |
| Otsuka America Pharmaceutical, Inc. | 6 | $162 |
| Neurocrine BioSciences, Inc. | 5 | $139 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Luye Pharma (USA) Ltd. | 1 | $19 |
Products named: COBENFY, INVEGA SUSTENNA, ABILIFY MAINTENA, ABILIFY ASIMTUFII, VIVITROL, INGREZZA, ARISTADA, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
